MedTrace Logo

The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study

NCT02736357 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2023-06-22

No results posted yet for this study

Summary

The goal of this infrastructure grant is to establish and maintain a cohort of over 12,000 non-Hodgkin lymphoma (NHL) patients to support broad and cutting-edge research that identifies clinical (including co-morbid diseases), epidemiologic (including lifestyle and other exposures), host genetic, tumor, and treatment factors, as well as the interaction among these factors, on short and long-term outcomes. These efforts will identify new approaches to improve the survival and well-being of NHL patients.

Conditions

Sponsors & Collaborators

  • Emory University

    collaborator OTHER

  • University of Iowa

    collaborator OTHER

  • M.D. Anderson Cancer Center

    collaborator OTHER

  • Washington University School of Medicine

    collaborator OTHER

  • University of Rochester

    collaborator OTHER

  • Weill Medical College of Cornell University

    collaborator OTHER

  • University of Miami

    collaborator OTHER

  • Mayo Clinic

    lead OTHER

Principal Investigators

  • James Cerhan, MD, PhD · Mayo Clinic

  • Christopher Flowers, MD · Emory University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-01
Primary Completion
2023-04-17
Completion
2023-04-17

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02736357 on ClinicalTrials.gov